S. Korea’s SK bioscience to acquire German biotech firm IDT Biologika
Seoul, June 27 (IANS) SK bioscience, a biopharmaceutical arm of South Korea's SK Group, on Thursday said it has agreed to pay 339 billion won ($243 million) for control of German biotech company IDT Biologika.According to the company…
Read More...
Read More...